Literature DB >> 29420684

Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.

Ming Hao, Stephen H Bryant, Yanli Wang.   

Abstract

While novel technologies such as high-throughput screening have advanced together with significant investment by pharmaceutical companies during the past decades, the success rate for drug development has not yet been improved prompting researchers looking for new strategies of drug discovery. Drug repositioning is a potential approach to solve this dilemma. However, experimental identification and validation of potential drug targets encoded by the human genome is both costly and time-consuming. Therefore, effective computational approaches have been proposed to facilitate drug repositioning, which have proved to be successful in drug discovery. Doubtlessly, the availability of open-accessible data from basic chemical biology research and the success of human genome sequencing are crucial to develop effective in silico drug repositioning methods allowing the identification of potential targets for existing drugs. In this work, we review several chemogenomic data-driven computational algorithms with source codes publicly accessible for predicting drug-target interactions (DTIs). We organize these algorithms by model properties and model evolutionary relationships. We re-implemented five representative algorithms in R programming language, and compared these algorithms by means of mean percentile ranking, a new recall-based evaluation metric in the DTI prediction research field. We anticipate that this review will be objective and helpful to researchers who would like to further improve existing algorithms or need to choose appropriate algorithms to infer potential DTIs in the projects. The source codes for DTI predictions are available at: https://github.com/minghao2016/chemogenomicAlg4DTIpred. Published by Oxford University Press 2018. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  chemogenomic data; drug discovery; drug–target interaction; in silico drug repositioning; mean percentile ranking; open-source code

Mesh:

Year:  2019        PMID: 29420684      PMCID: PMC6781586          DOI: 10.1093/bib/bby010

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  61 in total

Review 1.  Drug repositioning: identifying and developing new uses for existing drugs.

Authors:  Ted T Ashburn; Karl B Thor
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

2.  Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization.

Authors:  Mehmet Gönen
Journal:  Bioinformatics       Date:  2012-06-23       Impact factor: 6.937

Review 3.  Anti-HIV drugs for cancer therapeutics: back to the future?

Authors:  Warren A Chow; Chunling Jiang; Min Guan
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

4.  Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.

Authors:  Ming Hao; Yan Li; Yonghua Wang; Yulian Yan; Shuwei Zhang; Guohui Li; Ling Yang
Journal:  J Chem Inf Model       Date:  2011-09-29       Impact factor: 4.956

5.  Relating protein pharmacology by ligand chemistry.

Authors:  Michael J Keiser; Bryan L Roth; Blaine N Armbruster; Paul Ernsberger; John J Irwin; Brian K Shoichet
Journal:  Nat Biotechnol       Date:  2007-02       Impact factor: 54.908

6.  Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.

Authors:  Xuben Hou; Kangshuai Li; Xiao Yu; Jin-peng Sun; Hao Fang
Journal:  J Chem Inf Model       Date:  2015-09-17       Impact factor: 4.956

7.  In silico identification of structure requirement for novel thiazole and oxazole derivatives as potent fructose 1,6-bisphosphatase inhibitors.

Authors:  Ming Hao; Xiaole Zhang; Hong Ren; Yan Li; Shuwei Zhang; Fang Luo; Mingjuan Ji; Guohui Li; Ling Yang
Journal:  Int J Mol Sci       Date:  2011-11-18       Impact factor: 5.923

8.  Predicting drug-target interactions using restricted Boltzmann machines.

Authors:  Yuhao Wang; Jianyang Zeng
Journal:  Bioinformatics       Date:  2013-07-01       Impact factor: 6.937

9.  Assessing drug target association using semantic linked data.

Authors:  Bin Chen; Ying Ding; David J Wild
Journal:  PLoS Comput Biol       Date:  2012-07-05       Impact factor: 4.475

10.  Predicting drug-target interactions using drug-drug interactions.

Authors:  Shinhyuk Kim; Daeyong Jin; Hyunju Lee
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more
  6 in total

1.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

2.  Similarity-Based Methods and Machine Learning Approaches for Target Prediction in Early Drug Discovery: Performance and Scope.

Authors:  Neann Mathai; Johannes Kirchmair
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

3.  Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins.

Authors:  Sina Ghadermarzi; Xingyi Li; Min Li; Lukasz Kurgan
Journal:  Front Genet       Date:  2019-11-15       Impact factor: 4.599

4.  A Machine Learning-Based Biological Drug-Target Interaction Prediction Method for a Tripartite Heterogeneous Network.

Authors:  Ying Zheng; Zheng Wu
Journal:  ACS Omega       Date:  2021-01-21

5.  Novel drug-target interactions via link prediction and network embedding.

Authors:  E Amiri Souri; R Laddach; S N Karagiannis; L G Papageorgiou; S Tsoka
Journal:  BMC Bioinformatics       Date:  2022-04-04       Impact factor: 3.169

Review 6.  Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.

Authors:  Maryam Bagherian; Elyas Sabeti; Kai Wang; Maureen A Sartor; Zaneta Nikolovska-Coleska; Kayvan Najarian
Journal:  Brief Bioinform       Date:  2021-01-18       Impact factor: 11.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.